首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

2126716

大容量注射劑市場：按治療類型、最終用戶和地區分類

Large Volume Parenteral Market, By Treatment Type, By End User, By Geography

出版日期: 2026年08月03日 | 出版商:

Coherent Market Insights | 英文 259 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，大容量注射劑市場在2026年將達到92.5億美元，預計2033年將達到128.9億美元。預計從2026年到2033年，其複合年成長率將達到4.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	92.5億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	4.90	2033年市場規模預測：	128.9億美元

受慢性病盛行率上升、靜脈輸液治療日益普及以及人們對輸液治療方案日益成長的需求所驅動，市場正經歷重大變革。大容量腸外營養製劑，如生理食鹽水、葡萄糖、乳酸林格氏液、營養補充品和電解質製劑，使醫護人員能夠有效率地輸注液體，同時滿足補液、藥物稀釋、電解質平衡調節、營養支持和緊急醫療需求等需求。該市場涵蓋廣泛的應用領域，包括輸液治療、腸外營養、藥物配製、血液容積補充、腎臟護理和外科手術支援。

病人和醫護人員正致力於使用無菌輸液產品和給藥方法，以提高治療效果、確保可靠的輸液並保障病人安全。材料、密封包裝系統和污染預防機制的進步正在提升產品在醫院、加護病房和急診的性能。此外，預配溶液、居家輸液照護和標準化方案的日益普及，正在最佳化輸液治療和提高治療依從性，從而改善臨床療效並減輕急性和慢性疾病的管理負擔。

市場動態

由於疾病負擔加重、外科手術增加以及對靜脈輸液產品的需求不斷成長，該市場正蓬勃發展。市場成長的主要動力來自醫院和急救醫療機構對大量靜脈輸液的需求，尤其是在補液、電解質矯正、血液容積恢復、腸外營養、藥物稀釋和手術全期護理方面。容器完整性、軟性包裝、多層薄膜和污染預防系統在產品開發中發揮核心作用，有助於維持無菌狀態、延長保存期限、降低操作風險並支持可靠的輸液。生命維持急救系統的開發、醫院容量的擴大以及對輸液治療標準化的日益重視，都在推動對大容量腸外製劑的需求。

靜脈輸液治療程序的擴展正在推動市場成長。這主要是由於住院人數的增加、脫水和感染疾病的增多，以及生理食鹽水、葡萄糖、乳酸林格氏液和營養補充劑在患者群體中的廣泛應用。與非PVC輸液袋、雙腔容器、瓶蓋和即用型製劑相關的產品開發，有助於簡化輸液流程、減少配製錯誤，並確保液體和營養物質輸送的穩定性。

對高可靠性無菌溶液日益成長的需求也推動了市場擴張。醫生、藥劑師、護士、採購團隊、契約製造、經銷商和家庭輸液服務提供者在選擇和供應大容量注射方面發揮著至關重要的作用。隨著醫療服務效率的提高，市場有望受益於產能的提升、包裝安全性的提高、供應鏈韌性的增強以及穩定、適應性強且針對特定應用的輸液製劑的推出。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了高容量腸外給藥市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
《大容量注射藥物市場》報告的目標受群眾外包括該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析大批量注射藥物市場時使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Baxter International Inc.
- Teva Pharmaceutical Industries Limited
- Kelun Pharmaceutical Inc.
- BAG Healthcare GmbH
- Hospira, Inc.
- Patheon Inc.
- Otsuka Pharmaceutical
- Wockhardt Ltd.
- Southwest Pharmaceutical Co. Ltd.
- Cook Pharmica LLC.
分析師意見

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1323

Large Volume Parenteral Market is estimated to be valued at USD 9.25 Bn in 2026 and is expected to reach USD 12.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 9.25 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.90%	2033 Value Projection:	USD 12.89 Bn

The market is undergoing a major transformation driven by rising chronic disease prevalence, increasing adoption of intravenous therapies, and growing emphasis on fluid administration solutions. Large volume parenterals, including saline, dextrose, lactated Ringer's, nutritional, and electrolyte formulations, enable providers to deliver fluids efficiently while addressing hydration, medication dilution, electrolyte balance, nutritional support, and emergency care needs. The market includes a wide array of applications like fluid replacement, parenteral nutrition, drug reconstitution, blood volume expansion, renal care, and surgical support.

Patients and healthcare providers are focusing on sterile infusion products and administration approaches to enhance treatment effectiveness, ensure fluid delivery, and maintain patient safety. Advancements in materials, closed-system packaging, and contamination-control mechanisms are improving product performance across hospitals, intensive care units, and emergency departments. In addition, the growing use of ready-to-administer solutions, home infusion care, and standardized protocols helps optimize fluid therapy and treatment compliance, thereby improving clinical outcomes and reducing burden of acute and chronic disease management.

Market Dynamics

The market is witnessing momentum owing to the increasing burden of illnesses, rising number of surgical procedures, and growing demand for fluid replacement products. The market's growth is largely driven by hospitals and emergency care providers requiring high-volume intravenous solutions, particularly for hydration, electrolyte correction, blood volume restoration, parenteral nutrition, drug dilution, and perioperative care. Container integrity, flexible packaging, multilayer films, and contamination-control systems play a central role in product development, thereby helping maintain sterility, extend shelf life, reduce handling risks, and support reliable infusion delivery. The rising focus on critical care preparedness, hospital capacity expansion, and standardized fluid therapy is strengthening demand for large volume parenterals.

The expansion of intravenous treatment procedures is fueling market growth. This is mainly driven by increasing hospital admissions, rising dehydration and infections, and broader use of saline, dextrose, Ringer's lactate, and nutritional formulations across patient groups. Product developments involving non-PVC bags, dual-chamber containers, closures, and ready-to-use formulations help simplify administration, reduce preparation errors, and support consistent fluid and nutrient delivery.

The rising demand for dependable sterile solutions is also propelling the market. Physicians, pharmacists, nurses, procurement teams, contract manufacturers, distributors, and home infusion providers play a crucial role in selecting and supplying large volume parenterals. As healthcare delivery becomes efficiency-focused, the market is expected to benefit from expanded production capacity, improved packaging safety, stronger supply-chain resilience, and the introduction of stable, compatible, and application-specific infusion solutions.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Large Volume Parenteral Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Baxter International Inc., Teva Pharmaceutical Industries Limited, Kelun Pharmaceutical Inc., BAG Healthcare GmbH, Hospira, Inc., Patheon Inc., Otsuka Pharmaceutical, Wockhardt Ltd., Southwest Pharmaceutical Co. Ltd., and Cook Pharmica LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Large Volume Parenteral Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Large Volume Parenteral Market

Market Segmentation

By Application (Revenue, USD Bn, 2021-2033)
Fluid Balance Injections
Therapeutic Injections
Nutritious Injections
By End User (Revenue, USD Bn, 2021-2033)
Hospitals
Ambulatory centers
Clinics
Others
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players Insights
Baxter International Inc.
Teva Pharmaceutical Industries Limited
Kelun Pharmaceutical Inc.
BAG Healthcare GmbH
Hospira, Inc.
Patheon Inc.
Otsuka Pharmaceutical
Wockhardt Ltd.
Southwest Pharmaceutical Co. Ltd.
Cook Pharmica LLC.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Disease Type Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Large Volume Parenteral Market, By Treatment Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Fluid Balance Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Therapeutic Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Nutritious Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Large Volume Parenteral Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Ambulatory centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Large Volume Parenteral Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Baxter International Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Teva Pharmaceutical Industries Limited
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Kelun Pharmaceutical Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- BAG Healthcare GmbH
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Hospira, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Patheon Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Otsuka Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Wockhardt Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Southwest Pharmaceutical Co. Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cook Pharmica LLC.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views